Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

[The influence of Ara-C on anti-CD3/anti-Pgp mediating T-lymphocytes activities against multi-drug resistant leukemia cells.].

Yang M, Fan DM, Gao YD, Zhou Y, Ji Q, Shao XF, Wang JH, Xu YF, Xiong DS, Yang CZ.

Zhonghua Xue Ye Xue Za Zhi. 2009 Dec;30(12):812-5. Chinese.

PMID:
20193601
2.

[Specific targeting cytotoxicity to resistant leukemia cells mediated by anti-Pgp/anti-CD3 diabody].

Gao YD, Xiong DS, Yang M, Xu YF, Shao XF, Peng H, Fan DM, Yang CZ.

Zhonghua Xue Ye Xue Za Zhi. 2005 Jun;26(6):342-4. Chinese.

PMID:
16185477
3.

Efficient inhibition of multidrug-resistant human tumors with a recombinant bispecific anti-P-glycoprotein x anti-CD3 diabody.

Gao Y, Xiong D, Yang M, Liu H, Peng H, Shao X, Xu Y, Xu C, Fan D, Qin L, Yang C, Zhu Z.

Leukemia. 2004 Mar;18(3):513-20.

PMID:
14981526
4.

[Preparation and activity detection of monoclonal antibody against anti-CD3 ScFv].

Shao XF, Gao YD, Liu JN, Wang JH, Xu YF, Fan DM, Yang CZ, Xiong DS.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008 Jun;30(3):354-9. Chinese.

5.

[Construction and expression of anti-CD3/ anti-Pgp Diabody].

Gao YD, Xiong DS, Xu YF, Peng H, Shao XF, Yang CZ, Zhu ZP.

Sheng Wu Gong Cheng Xue Bao. 2003 Jul;19(4):444-9. Chinese.

PMID:
15969062
6.

Cytosine arabinoside promotes cytotoxic effect of T cells on leukemia cells mediated by bispecific antibody.

Li W, Fan D, Yang M, Yan Y, Shi R, Cheng J, Li Z, Zhang M, Wang J, Xiong D.

Hum Gene Ther. 2013 Aug;24(8):751-60. doi: 10.1089/hum.2013.051.

7.

Extracellular domain of 4-1BBL enhanced the antitumoral efficacy of peripheral blood lymphocytes mediated by anti-CD3 x anti-Pgp bispecific diabody against human multidrug-resistant leukemia.

Guo H, Jiang W, Liu W, Gao Y, Yang M, Zhou Y, Wang J, Qi J, Cheng X, Zhu Z, Yang C, Xiong D.

Cell Immunol. 2008 Feb;251(2):102-8. doi: 10.1016/j.cellimm.2008.04.006. Epub 2008 May 14.

PMID:
18482719
8.

[The role of extracellular domain of human 4-1BBL in regulating activities of human peripheral blood lymphocytes in vitro].

Guo HX, Cheng X, Su Y, Fan DM, Shao XF, Xu YF, Yang CZ, Xiong DS.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2008 May;24(5):431-3. Chinese.

PMID:
18466693
9.

Increased expression of insulin-like growth factor i is associated with Ara-C resistance in leukemia.

Abe S, Funato T, Takahashi S, Yokoyama H, Yamamoto J, Tomiya Y, Yamada-Fujiwara M, Ishizawa K, Kameoka J, Kaku M, Harigae H, Sasaki T.

Tohoku J Exp Med. 2006 Jul;209(3):217-28.

10.

Potentiation of cytotoxicity of 1-beta-D-arabinofuranosylcytosine for K562 human leukemic cells by cadeguomycin.

Suzuki H, Kim SH, Tanara M, Okazaki K, Okabe T, Wu RT, Tanaka N.

Cancer Res. 1987 Feb 1;47(3):713-7.

12.
13.

[Immunotherapy for leukemia cells by using cytotoxic T lymphocyte specifically against WT1-derived peptide: an experimental study in vitro].

Gu WY, Cao XS, Qiu GQ, Chen ZX, Sheng LX, Xie XB, He J, Cen JN, Shen HL.

Zhonghua Yi Xue Za Zhi. 2005 Dec 28;85(49):3475-80. Chinese.

PMID:
16686063
14.

cDNA microarray analysis of altered gene expression in Ara-C-treated leukemia cells.

Takagaki K, Katsuma S, Horio T, Kaminishi Y, Hada Y, Tanaka T, Ohgi T, Yano J.

Biochem Biophys Res Commun. 2003 Sep 19;309(2):351-8.

PMID:
12951057
15.

In vitro leukemia cell models of Ara-C resistance.

Funato T, Satou J, Nishiyama Y, Fujimaki S, Miura T, Kaku M, Sasaki T.

Leuk Res. 2000 Jun;24(6):535-41.

PMID:
10781689
16.

Characterization of cytarabine-resistant leukemic cell lines established from five different blood cell lineages using gene expression and proteomic analyses.

Negoro E, Yamauchi T, Urasaki Y, Nishi R, Hori H, Ueda T.

Int J Oncol. 2011 Apr;38(4):911-9. doi: 10.3892/ijo.2011.933. Epub 2011 Feb 2.

PMID:
21290089
17.

Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.

Atzpodien J, Wisniewski D, Gulati S, Welte K, Knowles R, Clarkson B.

Nat Immun Cell Growth Regul. 1987;6(3):129-40.

PMID:
3114621
18.

[Effect of combined administration of Angelica polysaccharide and cytarabine on liver of human leukemia NOD/SCID mouse model].

Zhu JH, Xu CY, Mu XY, Liu J, Zhang MS, Jia DY, Zhang YY, Huang GN, Wang YP.

Zhongguo Zhong Yao Za Zhi. 2014 Jan;39(1):121-5. Chinese.

PMID:
24754180

Supplemental Content

Support Center